Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Sol Gel Technologies Ltd - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
SLGL
Nasdaq
8731
http://www.sol-gel.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Sol Gel Technologies Ltd
Sol-Gel’s Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® Cream
- Apr 1st, 2024 11:00 am
Sol-Gel Technologies Full Year 2023 Earnings: Revenues Beat Expectations, EPS In Line
- Mar 14th, 2024 10:23 am
Sol-Gel Reports Full-Year 2023 Financial Results and Corporate Developments
- Mar 13th, 2024 11:00 am
Sol-Gel Technologies Screens First Patient for SGT-610 Phase 3 Study
- Nov 30th, 2023 12:00 pm
Sol-Gel Technologies Ltd to Host Virtual KOL Event on Gorlin Syndrome and the Upcoming Phase 3 Trial for SGT-610
- Nov 28th, 2023 1:06 pm
Is Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Trading At A 24% Discount?
- Nov 20th, 2023 10:31 am
Sol-Gel Technologies Reports Third Quarter 2023 Financial Results and Provides Corporate Update
- Nov 9th, 2023 12:00 pm
Zacks Industry Outlook Highlights Dr. Reddy's Laboratories, Amphastar Pharmaceuticals and Sol-Gel Technologies
- Oct 31st, 2023 10:43 am
3 Generic Drug Stocks to Watch Amid Improving Market Prospects
- Oct 30th, 2023 2:05 pm
Is Sol-Gel Technologies (NASDAQ:SLGL) In A Good Position To Invest In Growth?
- Oct 10th, 2023 11:47 am
Sol-Gel Technologies to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
- Aug 30th, 2023 12:00 pm
Sol-Gel Technologies Ltd. (SLGL) Reports Q2 Loss, Lags Revenue Estimates
- Aug 10th, 2023 12:15 pm
Sol-Gel Technologies Reports Second Quarter 2023 Financial Results and Provides Corporate Update
- Aug 10th, 2023 11:00 am
Sol-Gel Technologies Ltd.'s (NASDAQ:SLGL) Top Key Executive Moshe Arkin is the most upbeat insider, and their holdings increased by 15% last week
- Jul 21st, 2023 10:04 am
Sol-Gel and Searchlight Pharma Announce Licensing Agreements to Commercialize TWYNEO® and EPSOLAY® in Canada
- Jun 6th, 2023 11:30 am
Shareholders in Sol-Gel Technologies (NASDAQ:SLGL) are in the red if they invested five years ago
- Jun 2nd, 2023 10:09 am
Sol-Gel Technologies Ltd. (SLGL) Reports Q1 Loss, Tops Revenue Estimates
- May 12th, 2023 12:25 pm
Sol-Gel Technologies Reports First Quarter 2023 Financial Results and Provides Corporate Update
- May 12th, 2023 11:00 am
Scroll